Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 2Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Dermatologic 1

Conditions

Neoplasms 2Hemorrhage 2Thrombocytopenia 1Recurrence 1Postoperative Hemorrhage 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Melanoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Blood Loss, Surgical 1

Interventions

pembrolizumab 38Blood Specimen Collection 38Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 17Exercise 17Carboplatin 17Nivolumab 15atezolizumab 14Paclitaxel 14Cisplatin 14Drug Therapy 13Fluorouracil 12Cyclophosphamide 12Cetuximab 11Trastuzumab 10Pemetrexed 10Leucovorin 10Docetaxel 10Dexamethasone 10Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × Tranexamic Acid × Clear all
NCT05053867 2026-01-14

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Recruiting
60 enrolled
Tumor-Agnostic

Neoplasms

NCT05899465 2025-03-18

PRIME

University of Aarhus

Phase 3 Recruiting
1,204 enrolled
Dermatologic

Melanoma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡